In this article we goal to deliver a narrative review on the literature with regards to intraperitoneal pentobarbital to be a killing approach, evaluate its present designation as ‘acceptable’ (through the AVMA and CCAC), recognize gaps in awareness that may be pertinent on the refinement of this process, and suggest potential possibilities.Eli